Spanish Oncology Genito-urinary Group

This study reviewed medical records of 200 adults with advanced clear cell kidney cancer who received tivozanib as their first treatment. Researchers measured how long patients lived without the cancer getting worse. The goal was to see how well the drug works in everyday medical…

This study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) can help delay cancer growth in people with advanced urothelial cancer that did not worsen after initial chemotherapy. The trial enrolled 25 adults whose cancer was not removable by surg…